Response: Comment on: A Systematic Review and Meta-analysis of Patient Survival and Disease Recurrence Following Percutaneous Ablation of Pulmonary Metastasis
- PMID: 35859211
- DOI: 10.1007/s00270-022-03223-x
Response: Comment on: A Systematic Review and Meta-analysis of Patient Survival and Disease Recurrence Following Percutaneous Ablation of Pulmonary Metastasis
Comment on
-
A Systematic Review and Meta-analysis of Patient Survival and Disease Recurrence Following Percutaneous Ablation of Pulmonary Metastasis.Cardiovasc Intervent Radiol. 2022 Aug;45(8):1102-1113. doi: 10.1007/s00270-022-03116-z. Epub 2022 Mar 30. Cardiovasc Intervent Radiol. 2022. PMID: 35355094
References
-
- Nguyenhuy, M., et al., A Systematic Review and Meta-analysis of Patient Survival and Disease Recurrence Following Percutaneous Ablation of Pulmonary Metastasis. Cardiovasc Intervent Radiol, 2022.
-
- Lodeweges JE, et al. Long-term Outcome of Surgery or Stereotactic Radiotherapy for Lung Oligometastases. J Thorac Oncol. 2017;12(9):1442–5. - DOI
-
- Carmona C, et al. Shared decision-making: summary of NICE guidance. BMJ. 2021;373: n1430. - DOI
-
- Rusch VW. Pulmonary metastasectomy. Current indications Chest. 1995;107(6 Suppl):322S-331S. - DOI
-
- Gomez DR, et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016;17(12):1672–82. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical